MANAGEMENT OF SMALL-CELL CANCER OF THE LUNG
MANAGEMENT OF SMALL-CELL CANCER OF THE LUNG
复制标题
DOI：
10.1016/0140-6736(92)90287-d
复制
发表时间：
1992-04-04
期刊：
影响因子：
168.9
通讯作者：
HANSEN, HH
中科院分区：
文献类型：
--
作者：
HANSEN, HH
对过去二十年来小细胞肺癌（SCLC）患者治疗发生的变化进行了评论。将细胞毒性药物引入治疗方案;中位生存期增加; SCLC诊断;预后因素;退伍军人管理局肺癌研究组开发的分期系统;治疗，包括交替化疗;更多。
Comments on the changes that have taken place in the past two decades in the treatment of patients with small-cell lung cancer (SCLC). The introduction of cytotoxic drugs into treatment regimens; Increases in median survival; Diagnosis of SCLC; Prognostic factors; Staging system developed by the Veterans Administration Lung Cancer Study Group; Treatment, including alternating chemotherapy; More.